Laura Ingraham Attacks Promising Coronavirus Treatment after Hyping Unproven Malaria Drug

Laura Ingraham Attacks Promising Coronavirus Treatment after Hyping Unproven Malaria Drug

Fox News host Laura Ingraham, who spent weeks endlessly promoting the anti-malarial drug hydroxychloroquine as a possible coronavirus cure, downplayed data on Wednesday night that found another antiviral drug has shown actual promise as a treatment.

Noting that top infectious disease expert Dr. Anthony Fauci declared on Wednesday that results from a National Institutes of Health study into the Ebola drug remdesivir show a “clear-cut positive effect in diminishing time to recover,” Ingraham said that while it “certainly sounds encouraging” she’s not sure why Fauci wasn’t as bullish on hydroxychloroquine.

She went on to question the safety of remdesivir, which has been through numerous clinical trials over the years as an Ebola treatment. “We don’t know,” she stated. “It hasn’t been approved by the FDA. They might do emergency authorization. Hydroxychloroquine was approved decades ago.”

She also wondered aloud about remdesivir’s cost-effectiveness, insisting it is expensive and will be hard to scale up for production. As for hydroxychloroquine, Ingraham helpfully explained that it is “cheap and already widely available.”

Ingraham then welcomed on frequent guest Dr. Ramin Oskui, who she recently brought with her to the White House to sell President Donald Trump on hydroxychloroquine. Grumbling that the NIH results on remdesivir haven’t been peer-reviewed yet, Ingraham conceded that the initial analysis shows the drug cuts down on coronavirus recovery time.

Watch the video above, via Fox News.

Read the full article at The Daily Beast.

Contemptor Staff

Contemptor Staff